WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Top Chinese diplomat meets with executive secretary of ESCAP
China calls for efforts to promote Colombia's national development
UN chief calls for restraint after Iran's retaliatory attacks on Israel
China launches satellite to monitor marine, space environments
Program to boost cultural exchanges between China and France
Young giant panda Qing Ci dies from rare intestinal disorder
Xi Says to Continuously Consolidate, Develop China
Sweden raises policy rate to 2.5 pct to curb inflation
UN human rights chief condemns killings of women and children in Rafah
UK PM pledges to halve inflation, boost economy
UN human rights chief condemns killings of women and children in Rafah
China: Political settlement only viable way out of Ukraine crisis